Top 20 Life Science Startups to Watch in 2019
BioSpace is proud to present its NextGen Bio “Class of 2019,” a list of 20 up-and-coming life science companies in North America that launched* no earlier than 2017.
The NextGen Bio Class of 2019 is a stellar group of companies that are already making an enormous impact on the industry now and will continue into the future. Congratulations to this group!
Points : 17
Launched : 2018
Location : Waltham, MA
• In June 2018, Skyhawk Therapeutics closed a $40 million equity investment round and then, in an unusual deal, signed a five-year collaborative agreement with Celgene that included an upfront $60 million.
• Skyhawk focuses on developing small molecule therapeutics that correct RNA mis-splicing, what is usually called exon skipping.
• The company expects to move its first oncology treatment into the clinic in 2019.
• Skyhawk currently has four targets in oncology and three in neuro, which are in lead selection but past preclinical IND filing.